Replies to post #511206 on NorthWest Biotherapeutics Inc (NWBO)

[HyGro]

Once again NWBO has shown that is a false claim.

PIP is a pediatric trial design for post approval use and nothing else -- it is NOT any kind of commercial approval. It is a prerequisite for filing an application for approval. But NWBO has said in their recent filings that NO regulatory application for commercial approval have been filed.

After NWBO stated the new trial protocol and SAP in their SEC filings they repeatedly said: "There can be no assurance that regulatory authorities will allow a product approval to be based upon this approach." Which says NO regulator has vetted their new protocol/SAP. I'll believe NWBO's SEC filings under oath and penalty of perjury.